Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling

J Cardiovasc Pharmacol. 2006 Feb;47(2):228-35. doi: 10.1097/01.fjc.0000200989.23987.b8.

Abstract

Background: A cause-effect relationship has been established between MMP activation and left ventricular (LV) remodeling following myocardial infarction. The goal of the present study was to examine a selective MMP inhibitor (sMMPi) strategy that effectively spared MMP-1, -3, and -7 with effect to regional and global left ventricular remodeling in a pig model of myocardial infarction.

Methods and results: Pigs instrumented with coronary snares and radiopaque markers within the area at risk were randomized to myocardial infarction-only (n = 10) or sMMPi (PGE-530742, 1 mg/kg TID) begun 3 days prior to myocardial infarction. Ten weight-matched noninstrumented pigs served as reference controls. Left ventricular end-diastolic volume in the myocardial infarction-only group was increased from baseline (81 +/- 3 mL versus 55 +/- 4 mL, respectively, P < 0.05) but was attenuated with sMMPi (67 +/- 3 mL, P < 0.05). Fractional area of shortening of marker area was decreased in the myocardial infarction-only group (change from baseline -63 +/- 10%, P < 0.05) but this effect was attenuated with sMMPi (-28 +/- 14%, P < 0.05), indicative of less dyskinesis of the infarct region with sMMPi. Wall stress was reduced within both the septal and posterior wall regions with sMMPi. Myocardial MMP-2 activity was decreased in both remote and border areas of sMMPi-treated samples compared with myocardial infarction-only values, consistent with pharmacologic MMP inhibition.

Conclusions: Selective MMP inhibition favorably affected regional myocardial geometry and decreased left ventricular dilation post-myocardial infarction. This study suggests that a strategy of selective MMP inhibition of a limited array of MMPs may be an achievable goal in preventing pathologic left ventricular remodeling post-myocardial infarction.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Echocardiography
  • Fluoroscopy
  • Matrix Metalloproteinase Inhibitors*
  • Matrix Metalloproteinases / physiology*
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / enzymology
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology
  • Myocardium / pathology
  • Protease Inhibitors / administration & dosage
  • Protease Inhibitors / therapeutic use*
  • Random Allocation
  • Swine
  • Time Factors
  • Tissue Inhibitor of Metalloproteinases / pharmacokinetics
  • Tissue Inhibitor of Metalloproteinases / pharmacology
  • Tissue Inhibitor of Metalloproteinases / therapeutic use*
  • Ventricular Remodeling / drug effects*
  • Ventricular Remodeling / physiology

Substances

  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Tissue Inhibitor of Metalloproteinases
  • Matrix Metalloproteinases